Stoneridge Investment Partners’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-117,958
Closed -$195K 151
2024
Q3
$195K Hold
117,958
0.07% 94
2024
Q2
$262K Buy
117,958
+24,557
+26% +$54.5K 0.1% 97
2024
Q1
$250K Buy
93,401
+64,145
+219% +$172K 0.1% 95
2023
Q4
$87K Hold
29,256
0.04% 88
2023
Q3
$29K Hold
29,256
0.01% 99
2023
Q2
$41K Buy
+29,256
New +$41K 0.02% 106